Skip to main content
Journal cover image

Cognitive burden of anticholinergic medications in psychotic disorders.

Publication ,  Conference
Eum, S; Hill, SK; Rubin, LH; Carnahan, RM; Reilly, JL; Ivleva, EI; Keedy, SK; Tamminga, CA; Pearlson, GD; Clementz, BA; Gershon, ES ...
Published in: Schizophr Res
December 2017

BACKGROUND: Patients with psychotic disorders are often treated with numerous medications, many of which have anticholinergic activity. We assessed cognition in relation to the cumulative anticholinergic burden of multiple drugs included in treatment regimens of participants from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study. METHOD: Clinically stable participants with schizophrenia (n=206), schizoaffective disorder (n=131), and psychotic bipolar disorder (n=146) were examined. Anticholinergic properties of all scheduled drugs were quantified using the Anticholinergic Drug Scale (ADS). ADS scores were summed across individual drugs to create a total ADS burden score for each participant and examined in relation to the Brief Assessment of Cognition in Schizophrenia (BACS). RESULTS: Anticholinergic burden aggregated across all medications was inversely related to cognitive performance starting at ADS scores of 4 in participants with schizophrenia. Those with ADS scores ≥4 had lower composite BACS scores compared to those with ADS<4 (p=0.004). Among BACS subtests, Verbal Memory was the most adversely affected by high anticholinergic burden. Despite similar anticholinergic burden scores across groups, a significant threshold effect of anticholinergic burden was not detected in schizoaffective or psychotic bipolar disorder. CONCLUSION: We identified an adverse effect threshold of anticholinergic burden on cognition in clinically stable participants with schizophrenia. This relationship was not identified in affective psychoses. Examination of other medications, doses, and clinical measures did not account for these findings. Patients with schizophrenia may have increased cognitive susceptibility to anticholinergic medications and the aggregate effects of one's medication regimen may be important to consider in clinical practice.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Schizophr Res

DOI

EISSN

1573-2509

Publication Date

December 2017

Volume

190

Start / End Page

129 / 135

Location

Netherlands

Related Subject Headings

  • Schizophrenic Psychology
  • Schizophrenia
  • Psychotic Disorders
  • Psychiatry
  • Nasal Provocation Tests
  • Male
  • Interview, Psychological
  • Humans
  • Female
  • Cognition Disorders
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Eum, S., Hill, S. K., Rubin, L. H., Carnahan, R. M., Reilly, J. L., Ivleva, E. I., … Bishop, J. R. (2017). Cognitive burden of anticholinergic medications in psychotic disorders. In Schizophr Res (Vol. 190, pp. 129–135). Netherlands. https://doi.org/10.1016/j.schres.2017.03.034
Eum, Seenae, S Kristian Hill, Leah H. Rubin, Ryan M. Carnahan, James L. Reilly, Elena I. Ivleva, Sarah K. Keedy, et al. “Cognitive burden of anticholinergic medications in psychotic disorders.” In Schizophr Res, 190:129–35, 2017. https://doi.org/10.1016/j.schres.2017.03.034.
Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, et al. Cognitive burden of anticholinergic medications in psychotic disorders. In: Schizophr Res. 2017. p. 129–35.
Eum, Seenae, et al. “Cognitive burden of anticholinergic medications in psychotic disorders.Schizophr Res, vol. 190, 2017, pp. 129–35. Pubmed, doi:10.1016/j.schres.2017.03.034.
Eum S, Hill SK, Rubin LH, Carnahan RM, Reilly JL, Ivleva EI, Keedy SK, Tamminga CA, Pearlson GD, Clementz BA, Gershon ES, Keshavan MS, Keefe RSE, Sweeney JA, Bishop JR. Cognitive burden of anticholinergic medications in psychotic disorders. Schizophr Res. 2017. p. 129–135.
Journal cover image

Published In

Schizophr Res

DOI

EISSN

1573-2509

Publication Date

December 2017

Volume

190

Start / End Page

129 / 135

Location

Netherlands

Related Subject Headings

  • Schizophrenic Psychology
  • Schizophrenia
  • Psychotic Disorders
  • Psychiatry
  • Nasal Provocation Tests
  • Male
  • Interview, Psychological
  • Humans
  • Female
  • Cognition Disorders